Filing Flows › Astrana Health (ASTH) › Guidance & outlook
Astrana Health (ASTH) guidance and outlook
Astrana Health (ASTH) raised some and lowered other parts of its guidance on Nov 5, 2026: Revenue $939M for ; EBITDA $48.5M for ; Free cash flow $108M for ; Net income $3.1M for . Astrana Health's 10-Q filed Nov 6, 2026 makes 6 forward-looking statements.
Guidance and outlook
Latest guidance
| Metric | Period | Range | Change |
|---|---|---|---|
| Revenue | $939M | lowered | |
| EBITDA | $48.5M | lowered | |
| Free cash flow | $108M | raised | |
| Net income | $3.1M | lowered | |
| Interest expense | $9.8M | lowered | |
| Depreciation & amortization | $15.3M | lowered | |
| EBITDA | $32.9M | lowered | |
| Stock-based compensation | $12.8M | lowered |
From the earnings release filed Nov 5, 2026 (8-K on EDGAR).
Forward-looking statements, 10-Q filed Nov 6, 2026
- Leveraging our proprietary population health management and healthcare delivery platform, we operate an integrated, value-based healthcare model that aims to empower the providers in our network to deliver the highest quality of care in a cost-effective manner.
- However, there can be no assurance that these remediation efforts will be successful, that we have identified all information that was accessed or acquired, or that the measures we have implemented or may implement will prevent future cybersecurity incidents.
- We expect to continue to incur costs related to the incident, for ongoing fees to cybersecurity experts and other advisors, as well as additional remediation, litigation, and notification-related expenses and costs.
- We maintain cybersecurity insurance that is expected to offset a portion of potential losses and costs from the Cybersecurity Incident.
- Other, net, for the nine months ended September 30, 2026 relates to post-acquisition integration costs, an allowance on receivables that the Company plans to recover from the payer, non-routine legal matters, severance, and a fair value remeasurement of a previously held equity method investment that is now fully acquired, partially offset by non-cash changes to the fair value of an equity purchase financing…
- GAAP requires our management to make judgments, assumptions, and estimates that affect the amounts of revenue, expenses, income, assets, and liabilities reported in our condensed consolidated financial statements and accompanying notes.
Astrana Health's latest quarter
Astrana Health, Q3 2026: revenue $1.0B (+7% year over year), operating margin 3.9%, net earnings $13.0M, operating cash flow $16.3M. The chart follows the revenue to costs, profit and cash.
Questions
Did Astrana Health raise or lower its guidance?
Astrana Health (ASTH) raised some and lowered other parts of its guidance on Nov 5, 2026: Revenue $939M for ; EBITDA $48.5M for ; Free cash flow $108M for ; Net income $3.1M for .
What does Astrana Health expect?
Leveraging our proprietary population health management and healthcare delivery platform, we operate an integrated, value-based healthcare model that aims to empower the providers in our network to deliver the highest quality of care in a cost-effective manner. However, there can be no assurance that these remediation efforts will be successful, that we have identified all information that was accessed or acquired, or that the measures we have implemented or may implement will prevent future cybersecurity incidents. We expect to continue to incur costs related to the incident, for ongoing fees
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.